Conditions: Diabetes Mellitus, Type 2
Keywords: rosiglitazone Avandia type 2 diabetes mellitus diabetes
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 149
Healthy volunteers: no

Brief summary:
This study was designed to compare the efficacy and safety of BRL49653C versus placebo with concomitant use of sulfonyl urea (SU).

Detailed description:

Arms:
arm 1: study drug

Interventions: intervention 1: Rosiglitazone (BRL49653C)
Intervention descriptions: intervention 1: study drug

Protocol document: